It is controversial whether psychotic features are a risk factor for relapse in patients with electroconvulsive therapy‐responsive major depressive disorder. A recent study reported that benzodiazepine receptor agonists reduce relapse… Click to show full abstract
It is controversial whether psychotic features are a risk factor for relapse in patients with electroconvulsive therapy‐responsive major depressive disorder. A recent study reported that benzodiazepine receptor agonists reduce relapse of psychotic depression. As long‐term use of these agonists may induce dependence, further research is required. We examined whether psychotic features are associated with rehospitalization in electroconvulsive therapy‐responsive major depressive disorder patients. We also investigated whether taking benzodiazepine receptor agonists at the end of electro‐convulsive therapy was associated with rehospitalization among patients with psychotic depression.
               
Click one of the above tabs to view related content.